title: Effect of lithium on tachykinins, calcitonin gene-related peptide, and neuropeptide Y in rat brain.
abstract: The effects of lithium on brain regional concentrations of substance P (SP)-, neurokinin A (NKA)-, calcitonin gene-related peptide (CGRP)- and neuropeptide Y (NPY)-like immunoreactivities (-LI) were studied in rat. In the pilot study, rats were divided into three groups that were administered vehicle, or 1 or 4 mEq/kg lithium sulphate, respectively, intraperitoneally once/day for 9 days. In the second experiment, rats were divided into three groups receiving vehicle, or 1 or 2 mEq/kg lithium sulphate, respectively, intraperitoneally twice/day for 9 days. After sacrifice by focused microwave irradiation, brains were dissected, weighed, and frozen. Peptides were extracted and measured in extract aliquots by specific radioimmunoassays. Marked regional differences (P less than .001) were found for each of the peptides measured. In the pilot study the higher lithium dose, 4 mEq/kg, significantly raised neuropeptide levels. However, animals receiving this dose also showed signs of toxicity. In the second experiment, lithium increased SP-LI concentrations in striatum and hypothalamus (72 and 29%, P's less than .001 and .05). NKA-LI was also elevated in striatum (44%, P less than .01). CGRP-LI, in parallel to SP-LI, was increased in striatum and hypothalamus (58 and 78%, P's less than .05 and .01). In contrast, lithium decreased CGRP-LI in the pituitary gland (56%, P less than .01). NPY-LI was increased in striatum, and frontal and occipital cortex (30, 66, and 60%, respectively; P's less than .01, .01, and .05).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Psychiatry, St Göran's Hospital, Stockholm, Sweden.
authors.forename: A A
authors.initials: AA
authors.lastname: Mathé
authors.forename: J
authors.initials: J
authors.lastname: Jousisto-Hanson
authors.forename: C
authors.initials: C
authors.lastname: Stenfors
authors.forename: E
authors.initials: E
authors.lastname: Theodorsson
mesh_terms: D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D015740:Calcitonin Gene-Related Peptide / Q000378:metabolism*; D007150:Immunohistochemistry; D008094:Lithium / Q000494:pharmacology*; D008297:Male; D009478:Neuropeptide Y / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D015320:Tachykinins / Q000378:metabolism*
chemical_list: D009478:Neuropeptide Y; D015320:Tachykinins; D008094:Lithium; D015740:Calcitonin Gene-Related Peptide